Richard Mollard:
Director: Amphicell Pty Ltd
Owner: Bivalin
Education:
- BSc: University of Melbourne
- BSc (Hons): Monash University, Department of Anatomy (sole Departmental Scholarship recipient)
- PhD: Monash University, Molecular and Developmental Biology (High Priority Australian Post Graduate Research Award)
- MBA: Melbourne Business School, University of Melbourne, University of St Gallen School of Economics and Business Management, Switzerland
Preclinical Research, Drug Development, Large Pharma (since 1997):
- Bristol Myers Squibb and Université Louis-Pasteur (L’institut de génétique et de biologie moléculaire et cellulaire (IGBMC), France)
- Louis Pasteur Fellow
- Institut National de la Santé et de la Recherche Médicale (INSERM) Fellow,
- Eli Lilly and Co and University of Michigan, USA
- Monash University, Australia, and
- University of Melbourne, Australia (present Honorary).
Small- and Mid-Cap Biotech and Pharmaceutical Company Experience (since 2006):
- Bivalin: Board and Executive consultancies (Agenix Ltd, Bei Biotechnologies Ltd, Bionest Partners SARL, Immuron Ltd, Neurizon Ltd, PHI Vietnam Holdings Inc, QEDDI, Regeneus Ltd, Smart Cells International Ltd)
- Biotech and Biopharma CEO, CSO, CCO, COO: ASX listed (Pharmaust Ltd), public unlisted (Myopharm Ltd) and private companies (Mucpharm Pty Ltd, Pitney Pharmaceuticals Pty Ltd, SteMing Asia Ltd)
- linkedin.com/in/ramollard
Relevant Tissue Culture Experience:
- Frog and tadpole somatic cells (here)
- Human cancer cell lines
- Primary mouse lung cells
- Mouse lung organoids
- Macaque (Macaca fascicularis) lung organoids
- Mouse kidney organoids
- Mouse pituitary organoids
- Human and mouse mesenchymal stem cells
- Human and mouse embryonic stem cells
- Human and mouse neural stem cells
- Human and mouse haematopoietic stem cells
- Mouse embryos: two cell embryo to hatched blastocyst
- Mouse fetal cultures: D7 to D11 equivalent
- Zebrafish pineal gland/cells